Ingevity (NGVT)
(Delayed Data from NYSE)
$48.85 USD
+0.84 (1.75%)
Updated May 31, 2024 04:00 PM ET
After-Market: $48.89 +0.04 (0.08%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Brokerage Reports
0 items in cart
Ingevity Corporation [NGVT]
Reports for Purchase
Showing records 121 - 140 ( 238 total )
Company: Ingevity Corporation
Industry: Chemical - Specialty
Provider: Zacks Investment Research
Analyst: Research Department
Company: Ingevity Corporation
Industry: Chemical - Specialty
Provider: Zacks Investment Research
Analyst: Research Department
Company: Ingevity Corporation
Industry: Chemical - Specialty
Provider: Zacks Investment Research
Analyst: Research Department
Company: Ingevity Corporation
Industry: Chemical - Specialty
Specialty Chemicals: Suspending Coverage
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Ingevity Corporation
Industry: Chemical - Specialty
Provider: Zacks Investment Research
Analyst: Research Department
Company: Ingevity Corporation
Industry: Chemical - Specialty
Company: Ingevity Corporation
Industry: Chemical - Specialty
Company: Ingevity Corporation
Industry: Chemical - Specialty
Difficult to Cap the Growth, Strong DD Outlook Maintained
Provider: KEYBANC CAPITAL MARKETS
Analyst: SISON M
Company: Ingevity Corporation
Industry: Chemical - Specialty
Adj. EPS of $1.36 Ahead of Consensus; Guidance Maintained
Provider: KEYBANC CAPITAL MARKETS
Analyst: SISON M
Company: Ingevity Corporation
Industry: Chemical - Specialty
Company: Ingevity Corporation
Industry: Chemical - Specialty
Company: Ingevity Corporation
Industry: Chemical - Specialty
Company: Ingevity Corporation
Industry: Chemical - Specialty
Company: Ingevity Corporation
Industry: Chemical - Specialty
Specialty Chemicals Leading Indicators Through April 2019
Provider: KEYBANC CAPITAL MARKETS
Analyst: SISON M
Company: Ingevity Corporation
Industry: Chemical - Specialty
Company: Ingevity Corporation
Industry: Chemical - Specialty
Company: Ingevity Corporation
Industry: Chemical - Specialty
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Ingevity Corporation
Industry: Chemical - Specialty
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Ingevity Corporation
Industry: Chemical - Specialty
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Ingevity Corporation
Industry: Chemical - Specialty
Headwinds Overwhelming Near Term? Not Today, 20%+ EBITDA Growth on the Way
Provider: KEYBANC CAPITAL MARKETS
Analyst: SISON M